-
1
-
-
20144388435
-
Epidemiology and predictors of mortality in cases of Candida bloodstream infection: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003
-
Almirante, B., D. Rodriguez, B. J. Park, M. Cuenca-Estrella, A. M. Planes, M. Almela, J. Mensa, F. Sanchez, J. Ayats, M. Gimenez, P. Saballs, S. K. Fridkin, J. Morgan, J. L. Rodriguez-Tudela, D. W. Warnock, and A. Pahissa. 2005. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J. Clin. Microbiol. 43:1829-1835.
-
(2005)
J. Clin. Microbiol.
, vol.43
, pp. 1829-1835
-
-
Almirante, B.1
Rodriguez, D.2
Park, B.J.3
Cuenca-Estrella, M.4
Planes, A.M.5
Almela, M.6
Mensa, J.7
Sanchez, F.8
Ayats, J.9
Gimenez, M.10
Saballs, P.11
Fridkin, S.K.12
Morgan, J.13
Rodriguez-Tudela, J.L.14
Warnock, D.W.15
Pahissa, A.16
-
2
-
-
41949093350
-
Semi-national surveillance of fungaemia in Denmark 2004-2006: Increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility
-
Arendrup, M. C., K. Fuursted, B. Gahrn-Hansen, H. C. Schonheyder, J. D. Knudsen, I. M. Jensen, B. Bruun, J. J. Christensen, and H. K. Johansen. 2008. Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clin. Microbiol. Infect. 14:487-494.
-
(2008)
Clin. Microbiol. Infect.
, vol.14
, pp. 487-494
-
-
Arendrup, M.C.1
Fuursted, K.2
Gahrn-Hansen, B.3
Schonheyder, H.C.4
Knudsen, J.D.5
Jensen, I.M.6
Bruun, B.7
Christensen, J.J.8
Johansen, H.K.9
-
3
-
-
33644506461
-
Epidemiological trends in nosocomial candidemia in intensive care
-
Bassetti, M., E. Righi, A. Costa, R. Fasce, M. P. Molinari, R. Rosso, F. B. Pallavicini, and C. Viscoli. 2006. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect. Dis. 6:21.
-
(2006)
BMC Infect. Dis.
, vol.6
, pp. 21
-
-
Bassetti, M.1
Righi, E.2
Costa, A.3
Fasce, R.4
Molinari, M.P.5
Rosso, R.6
Pallavicini, F.B.7
Viscoli, C.8
-
4
-
-
0037096886
-
Antifungal prophylaxis for severely neutropenic chemotherapy recipients: A meta analysis of randomized-controlled clinical trials
-
Bow, E. J., M. Laverdiere, N. Lussier, C. Rotstein, M. S. Cheang, and S. Ioannou. 2002. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer 94:3230-3246.
-
(2002)
Cancer
, vol.94
, pp. 3230-3246
-
-
Bow, E.J.1
Laverdiere, M.2
Lussier, N.3
Rotstein, C.4
Cheang, M.S.5
Ioannou, S.6
-
5
-
-
70449723367
-
Blood stream infections by Candida glabrata and Candida krusei: A single-center experience
-
Choi, H. K., S. J. Jeong, H. S. Lee, B. S. Chin, S. H. Choi, S. H. Han, M. S. Kim, C. O. Kim, J. Y. Choi, Y. G. Song, and J. M. Kim. 2009. Blood stream infections by Candida glabrata and Candida krusei: a single-center experience. Korean J. Intern. Med. 24:263-269.
-
(2009)
Korean J. Intern. Med.
, vol.24
, pp. 263-269
-
-
Choi, H.K.1
Jeong, S.J.2
Lee, H.S.3
Chin, B.S.4
Choi, S.H.5
Han, S.H.6
Kim, M.S.7
Kim, C.O.8
Choi, J.Y.9
Song, Y.G.10
Kim, J.M.11
-
6
-
-
23044487160
-
Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia
-
Clancy, C. J., V. L. Yu, A. J. Morris, D. R. Snydman, and M. H. Nguyen. 2005. Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia. Antimicrob. Agents Chemother. 49:3171-3177.
-
(2005)
Antimicrob. Agents Chemother.
, vol.49
, pp. 3171-3177
-
-
Clancy, C.J.1
Yu, V.L.2
Morris, A.J.3
Snydman, D.R.4
Nguyen, M.H.5
-
7
-
-
33646455889
-
Antifungal prophylaxis in liver transplant patients: A systematic review and meta-analysis
-
Cruciani, M., C. Mengoli, M. Malena, O. Bosco, G. Serpelloni, and P. Grossi. 2006. Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis. Liver Transpl. 12:850-858.
-
(2006)
Liver Transpl.
, vol.12
, pp. 850-858
-
-
Cruciani, M.1
Mengoli, C.2
Malena, M.3
Bosco, O.4
Serpelloni, G.5
Grossi, P.6
-
8
-
-
66149156191
-
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds
-
Cuenca-Estrella, M., A. Gomez-Lopez, E. Mellado, A. Monzon, M. J. Buitrago, and J. L. Rodriguez-Tudela. 2009. Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrob. Agents Chemother. 53:2192-2195.
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 2192-2195
-
-
Cuenca-Estrella, M.1
Gomez-Lopez, A.2
Mellado, E.3
Monzon, A.4
Buitrago, M.J.5
Rodriguez-Tudela, J.L.6
-
9
-
-
34247181114
-
Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients
-
Davis, S. L., J. A. Vazquez, and P. S. McKinnon. 2007. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Ann. Pharmacother. 41:568-573.
-
(2007)
Ann. Pharmacother.
, vol.41
, pp. 568-573
-
-
Davis, S.L.1
Vazquez, J.A.2
McKinnon, P.S.3
-
10
-
-
38549163599
-
Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: Differences in risk factors and outcome
-
Dimopoulos, G., F. Ntziora, G. Rachiotis, A. Armaganidis, and M. E. Falagas. 2008. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth. Analg. 106:523-529.
-
(2008)
Anesth. Analg.
, vol.106
, pp. 523-529
-
-
Dimopoulos, G.1
Ntziora, F.2
Rachiotis, G.3
Armaganidis, A.4
Falagas, M.E.5
-
11
-
-
33746070016
-
Attributable mortality of candidemia: A systematic review of matched cohort and casecontrol studies
-
Falagas, M. E., K. E. Apostolou, and V. D. Pappas. 2006. Attributable mortality of candidemia: a systematic review of matched cohort and casecontrol studies. Eur. J. Clin. Microbiol. Infect. Dis. 25:419-425.
-
(2006)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.25
, pp. 419-425
-
-
Falagas, M.E.1
Apostolou, K.E.2
Pappas, V.D.3
-
12
-
-
53649097545
-
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: Results of a 3-year (2004 to 2007) surveillance study
-
Gonzalez, G. M., M. Elizondo, and J. Ayala. 2008. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. J. Clin. Microbiol. 46:2902-2905.
-
(2008)
J. Clin. Microbiol.
, vol.46
, pp. 2902-2905
-
-
Gonzalez, G.M.1
Elizondo, M.2
Ayala, J.3
-
13
-
-
0022256529
-
APACHE II: A severity of disease classification system
-
Knaus, W. A., E. A. Draper, D. P. Wagner, and J. E. Zimmerman. 1985. APACHE II: a severity of disease classification system. Crit. Care Med. 13:818-829.
-
(1985)
Crit. Care Med.
, vol.13
, pp. 818-829
-
-
Knaus, W.A.1
Draper, E.A.2
Wagner, D.P.3
Zimmerman, J.E.4
-
14
-
-
56049120807
-
Treatment-related risk factors for hospital mortality in Candida bloodstream infections
-
Labelle, A. J., S. T. Micek, N. Roubinian, and M. H. Kollef. 2008. Treatment-related risk factors for hospital mortality in Candida bloodstream infections. Crit. Care Med. 36:2967-2972.
-
(2008)
Crit. Care Med.
, vol.36
, pp. 2967-2972
-
-
Labelle, A.J.1
Micek, S.T.2
Roubinian, N.3
Kollef, M.H.4
-
15
-
-
61549111506
-
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections
-
Lee, I., N. O. Fishman, T. E. Zaoutis, K. H. Morales, M. G. Weiner, M. Synnestvedt, I. Nachamkin, and E. Lautenbach. 2009. Risk factors for fluconazole-resistant Candida glabrata bloodstream infections. Arch. Intern. Med. 169:379-383.
-
(2009)
Arch. Intern. Med.
, vol.169
, pp. 379-383
-
-
Lee, I.1
Fishman, N.O.2
Zaoutis, T.E.3
Morales, K.H.4
Weiner, M.G.5
Synnestvedt, M.6
Nachamkin, I.7
Lautenbach, E.8
-
16
-
-
27644585171
-
Prior antimicrobial therapy and risk for hospitalacquired Candida glabrata and Candida krusei fungemia: A case-case-control study
-
Lin, M. Y., Y. Carmeli, J. Zumsteg, E. L. Flores, J. Tolentino, P. Sreeramoju, and S. G. Weber. 2005. Prior antimicrobial therapy and risk for hospitalacquired Candida glabrata and Candida krusei fungemia: a case-case-control study. Antimicrob. Agents Chemother. 49:4555-4560.
-
(2005)
Antimicrob. Agents Chemother.
, vol.49
, pp. 4555-4560
-
-
Lin, M.Y.1
Carmeli, Y.2
Zumsteg, J.3
Flores, E.L.4
Tolentino, J.5
Sreeramoju, P.6
Weber, S.G.7
-
17
-
-
14744289081
-
Candida krusei fungaemia: Antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital
-
Muñoz, P., M. Sanchez-Somolinos, L. Alcala, M. Rodriguez-Creixems, T. Pelaez, and E. Bouza. 2005. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital. J. Antimicrob. Chemother. 55:188-193.
-
(2005)
J. Antimicrob. Chemother.
, vol.55
, pp. 188-193
-
-
Muñoz, P.1
Sanchez-Somolinos, M.2
Alcala, L.3
Rodriguez-Creixems, M.4
Pelaez, T.5
Bouza, E.6
-
19
-
-
33644596969
-
Invasive candidiasis in the intensive care unit
-
Ostrosky-Zeichner, L., and P. G. Pappas. 2006. Invasive candidiasis in the intensive care unit. Crit. Care Med. 34:857-863.
-
(2006)
Crit. Care Med.
, vol.34
, pp. 857-863
-
-
Ostrosky-Zeichner, L.1
Pappas, P.G.2
-
20
-
-
60549098868
-
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
-
Pappas, P. G., C. A. Kauffman, D. Andes, D. K. Benjamin, Jr., T. F. Calandra, J. E. Edwards, Jr., S. G. Filler, J. F. Fisher, B. J. Kullberg, L. Ostrosky-Zeichner, A. C. Reboli, J. H. Rex, T. J. Walsh, and J. D. Sobel. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
-
(2009)
Clin. Infect. Dis.
, vol.48
, pp. 503-535
-
-
Pappas, P.G.1
Kauffman, C.A.2
Andes, D.3
Benjamin Jr., D.K.4
Calandra, T.F.5
Edwards Jr., J.E.6
Filler, S.G.7
Fisher, J.F.8
Kullberg, B.J.9
Ostrosky-Zeichner, L.10
Reboli, A.C.11
Rex, J.H.12
Walsh, T.J.13
Sobel, J.D.14
-
21
-
-
34548138992
-
Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections
-
Parkins, M. D., D. M. Sabuda, S. Elsayed, and K. B. Laupland. 2007. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J. Antimicrob. Chemother. 60:613-618.
-
(2007)
J. Antimicrob. Chemother.
, vol.60
, pp. 613-618
-
-
Parkins, M.D.1
Sabuda, D.M.2
Elsayed, S.3
Laupland, K.B.4
-
22
-
-
0038627919
-
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location
-
Pfaller, M. A., S. A. Messer, L. Boyken, S. Tendolkar, R. J. Hollis, and D. J. Diekema. 2003. Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location. J. Clin. Microbiol. 41:2176-2179.
-
(2003)
J. Clin. Microbiol.
, vol.41
, pp. 2176-2179
-
-
Pfaller, M.A.1
Messer, S.A.2
Boyken, L.3
Tendolkar, S.4
Hollis, R.J.5
Diekema, D.J.6
-
23
-
-
47249139580
-
Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp
-
Playford, E. G., D. Marriott, Q. Nguyen, S. Chen, D. Ellis, M. Slavin, and T. C. Sorrell. 2008. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit. Care Med. 36:2034-2039.
-
(2008)
Crit. Care Med.
, vol.36
, pp. 2034-2039
-
-
Playford, E.G.1
Marriott, D.2
Nguyen, Q.3
Chen, S.4
Ellis, D.5
Slavin, M.6
Sorrell, T.C.7
-
24
-
-
77958560066
-
Predictors of non-albicans Candida species candidemia: Results of a population-based surveillance in Barcelona, Spain
-
6 March Epub ahead of print
-
Rodriguez, D., B. Almirante, M. Cuenca-Estrella, J. L. Rodriguez-Tudela, J. Mensa, J. Ayats, F. Sanchez, and A. Pahissa. 6 March 2010. Predictors of non-albicans Candida species candidemia: results of a population-based surveillance in Barcelona, Spain. Clin. Microbiol. Infect. [Epub ahead of print.]
-
(2010)
Clin. Microbiol. Infect.
-
-
Rodriguez, D.1
Almirante, B.2
Cuenca-Estrella, M.3
Rodriguez-Tudela, J.L.4
Mensa, J.5
Ayats, J.6
Sanchez, F.7
Pahissa, A.8
-
25
-
-
38049075818
-
Candida glabrata fungaemia in intensive care units
-
Ruan, S. Y., L. N. Lee, J. S. Jerng, C. J. Yu, and P. R. Hsueh. 2008. Candida glabrata fungaemia in intensive care units. Clin. Microbiol. Infect. 14:136-140.
-
(2008)
Clin. Microbiol. Infect.
, vol.14
, pp. 136-140
-
-
Ruan, S.Y.1
Lee, L.N.2
Jerng, J.S.3
Yu, C.J.4
Hsueh, P.R.5
-
26
-
-
47549089281
-
Empirical fluconazole versus placebo for intensive care unit patients: A randomized trial
-
Schuster, M. G., J. E. Edwards, Jr., J. D. Sobel, R. O. Darouiche, A. W. Karchmer, S. Hadley, G. Slotman, H. Panzer, P. Biswas, and J. H. Rex. 2008. Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann. Intern. Med. 149:83-90.
-
(2008)
Ann. Intern. Med.
, vol.149
, pp. 83-90
-
-
Schuster, M.G.1
Edwards Jr., J.E.2
Sobel, J.D.3
Darouiche, R.O.4
Karchmer, A.W.5
Hadley, S.6
Slotman, G.7
Panzer, H.8
Biswas, P.9
Rex, J.H.10
-
27
-
-
24944510786
-
Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis
-
Shorr, A. F., K. Chung, W. L. Jackson, P. E. Waterman, and M. H. Kollef. 2005. Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit. Care Med. 33:1928-1935.
-
(2005)
Crit. Care Med.
, vol.33
, pp. 1928-1935
-
-
Shorr, A.F.1
Chung, K.2
Jackson, W.L.3
Waterman, P.E.4
Kollef, M.H.5
-
28
-
-
34247099393
-
Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia
-
Shorr, A. F., D. R. Lazarus, J. H. Sherner, W. L. Jackson, M. Morrel, V. J. Fraser, and M. H. Kollef. 2007. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia. Crit. Care Med. 35:1077-1083.
-
(2007)
Crit. Care Med.
, vol.35
, pp. 1077-1083
-
-
Shorr, A.F.1
Lazarus, D.R.2
Sherner, J.H.3
Jackson, W.L.4
Morrel, M.5
Fraser, V.J.6
Kollef, M.H.7
-
29
-
-
77953721388
-
Candidaemia in adult cancer patients: Risks for fluconazole-resistant isolates and death
-
Slavin, M. A., T. C. Sorrell, D. Marriott, K. A. Thursky, Q. Nguyen, D. H. Ellis, C. O. Morrissey, and S. C. Chen. 2010. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. J. Antimicrob. Chemother. 65:1042-1051.
-
(2010)
J. Antimicrob. Chemother.
, vol.65
, pp. 1042-1051
-
-
Slavin, M.A.1
Sorrell, T.C.2
Marriott, D.3
Thursky, K.A.4
Nguyen, Q.5
Ellis, D.H.6
Morrissey, C.O.7
Chen, S.C.8
-
30
-
-
2942741307
-
Clinical factors associated with fluconazole resistance and short-term survival in patients with Candida bloodstream infection
-
Takakura, S., N. Fujihara, T. Saito, T. Kudo, Y. Iinuma, and S. Ichiyama. 2004. Clinical factors associated with fluconazole resistance and short-term survival in patients with Candida bloodstream infection. Eur. J. Clin. Microbiol. Infect. Dis. 23:380-388.
-
(2004)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.23
, pp. 380-388
-
-
Takakura, S.1
Fujihara, N.2
Saito, T.3
Kudo, T.4
Iinuma, Y.5
Ichiyama, S.6
-
31
-
-
33645833237
-
Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials
-
Vardakas, K. Z., G. Samonis, A. Michalopoulos, E. S. Soteriades, and M. E. Falagas. 2006. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit. Care Med. 34:1216-1224.
-
(2006)
Crit. Care Med.
, vol.34
, pp. 1216-1224
-
-
Vardakas, K.Z.1
Samonis, G.2
Michalopoulos, A.3
Soteriades, E.S.4
Falagas, M.E.5
|